Tryptophan for Impaired AhR Signaling in Celiac Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Tryptophan for Impaired AhR Signaling in Celiac Disease — Stella

Recruiting

Back to Tryptophan Metabolism Alterations trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

McMaster University, Hamilton, Ontario

Key details

Sponsor

McMaster University

Enrollment target

~50 participants

Started

December 2022

Primary completion

April 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov